Amlodipine and Clamminess - a phase IV clinical study of FDA data

Summary:

We study 322,024 people who have side effects when taking Amlodipine. Clamminess is found, especially among people who are male, 60+ old, also take Omeprazole.

The phase IV clinical study analyzes which people take Amlodipine and have Clamminess. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

322,024 people reported to have side effects when taking Amlodipine.
Among them, 11 people (0.0%) have Clamminess.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is used in high blood pressure. Currently, eHealthMe is studying from 329,375 Amlodipine users.

What is Clamminess?

Clamminess (moist, sticky, and cold to the touch) is found to be associated with 588 drugs and 57 conditions by eHealthMe. Currently, we are studying 1,446 people who have Clamminess.

Number of Amlodipine and Clamminess reports submitted per year:

Gender of people who have Clamminess when taking Amlodipine *:

female: 36.36 %
male: 63.64 %

Age of people who have Clamminess when taking Amlodipine *:

Common drugs people take besides Amlodipine *:

Omeprazole: 3 people, 27.27%
Famotidine: 2 people, 18.18%
Nifedipine: 2 people, 18.18%
Furosemide: 2 people, 18.18%
Zocor: 2 people, 18.18%
Ranitidine: 2 people, 18.18%
Lisinopril: 2 people, 18.18%
Cardura: 2 people, 18.18%
Physiosol In Plastic Container: 2 people, 18.18%
Digoxin: 1 person, 9.09%

Common side effects people have besides Clamminess *:

Sweating Increased (excess sweating): 3 people, 27.27%
Paleness (unusual lightness of skin colour): 3 people, 27.27%
Hypotension (abnormally low blood pressure): 3 people, 27.27%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 18.18%
Nausea (feeling of having an urge to vomit): 2 people, 18.18%
Itching: 2 people, 18.18%
Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 18.18%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 2 people, 18.18%
Sedation: 2 people, 18.18%
Depressed Level Of Consciousness: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Clamminess?

Check whether Clamminess is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Clamminess and when was it recovered:

Clamminess in Amlodipine

Expand to all the drugs that have ingredients of amlodipine besylate:

Clamminess and drugs with ingredients of amlodipine besylate

Alternative drugs to, pros and cons of Amlodipine:

Amlodipine (329,375 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Clamminess treatments and more:

Clamminess (1,446 reports)

All the drugs that are associated with Clamminess:

Clamminess (588 drugs)

All the conditions that are associated with Clamminess:

Clamminess (57 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.